1. Home >
  2. M&A >
  3. Divestiture >
  4. Australia >
  5. Upstryve Acquires Alchemia Oncology Pty

M&A Deal Summary

Upstryve Acquires Alchemia Oncology Pty

On July 1, 2015, Upstryve acquired life science company Alchemia Oncology Pty from Australian Primary Hemp

Acquisition Highlights
  • This is Upstryve’s 2nd transaction in the Life Science sector.
  • This is Upstryve’s 1st transaction in Australia.

M&A Deal Summary
Date 2015-07-01
Target Alchemia Oncology Pty
Sector Life Science
Buyer(s) Upstryve
Sellers(s) Australian Primary Hemp
Deal Type Divestiture

Target

Alchemia Oncology Pty

Clayton, Australia
Alchemia Oncology Pty Limited has a robust collection of clinical and pre-clinical oncology assets, which include the HyACT Drug Delivery Platform, a portfolio of targeted therapeutics which are designed to exploit the unique structure and inherent biological properties of Hyaluronic Acid. Drug candidates in the portfolio range from pre-clinical through phase 3. Panther intends to file a new phase 3 protocol against an open IND with the FDA for HA-Irinotecan in 2015, in addition to advancing the other phase 2 and phase 1b clinical drug candidates.

Search 214,239 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try Free

Buyer(S) 1

Buyer

Upstryve

Houston, Texas, United States
Category Company
Founded 2020
Sector Education
Revenue 9M USD (2017)
DESCRIPTION

Upstryve is an international education, training, and career advancement company with a focus on vocational and skilled trades headquartered in southern Florida. Upstryve operates through its four brands including Upstryve, One Exam Prep, North American Crane Bureau Group and Disco Learning Media. Upstryve was formed in 2020 and is based in Houston, Texas.

DEAL STATS #
Overall 2 of 5
Sector: Life Science M&A 2 of 2
Type: Divestiture M&A Deals 1 of 1
Country: Australia M&A 1 of 1
Year: 2015 M&A 2 of 2
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2015-04-07 Faulk Pharmaceuticals

Raleigh, North Carolina, United States

Faulk Pharmaceuticals is a biopharmaceutical company that is developing a novel technology platform to develop best-in-class drug formulations for cancer and other diseases. The Faulk technology employs chemical conjugation techniques to create powerful pairings of proteins and chemotherapeutic drug formulations that provide a targeting strategy and the predictable delivery of a therapeutic drug. The technology was specifically designed to circumvent many of the challenges associated with the development of drug resistance that so often occurs with many newer cancer therapies.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2017-06-27 Atlas Publishing

Houston, Texas, United States

W. Marketing, Inc. is a provider of widest selection of electrical and construction trade reference materials to engineers, electrical training instructors, builders, building maintenance and professionals in the construction and electrical industries. W. Marketing, Inc. was established in 2006 and is based in Houston, Texas.

Buy -

Seller(S) 1

SELLER

Australian Primary Hemp

Geelong, Australia
Category Company
Founded 2016
Sector Healthcare Services
Revenue 1M AUD (2020)
DESCRIPTION

Australian Primary Hemp has a proprietary drug discovery platform, VAST®, derived from Alchemia’s chemistry expertise. Australian Primary Hemp was founded in 2016 and is based in Geelong, Australia.

DEAL STATS #
Overall 1 of 1
Sector: Life Science M&A 1 of 1
Type: Divestiture M&A Deals 1 of 1
Country: Australia M&A 1 of 1
Year: 2015 M&A 1 of 1
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2007-06-29 Huta Bankowa Sp. z o.o.

Dabrowa Górnicza, Poland

Huta Bankowa Sp. z o.o. is a manufacturer and marketer of steel products.

Buy -
Mergr

Solution for

Product

Company

Legal